While mounting evidence has shown that the gut microbiota regulates amyloid deposition, there was a lack of information on the contribution of the gut microbiota to tau pathology and neurodegeneration, which is strongly correlated with cognitive decline in AD. This evidence concerns the gene MAPT and Alzheimer disease.